4TO vs NNNN: Side-by-Side Comparison
Compare MAINZ BIOMED B.V. EO 1 (4TO) and Anbio Biotechnology - Class A (NNNN) side by side: market cap EUR 4.55M vs USD 557.42M. Financials, growth and model signals on Bullrun.
| Metric | 4TO | NNNN |
|---|---|---|
| Company | MAINZ BIOMED B.V. EO 1 | Anbio Biotechnology - Class A |
| Country / Exchange | Germany · F | Germany · NASDAQ |
| Sector | Healthcare | Healthcare |
| Industry | Diagnostics & Research | Medical Instruments & Supplies |
| Market cap | EUR 4.55M | USD 557.42M |
| P/E ratio | — | — |
| Dividend yield | — | — |
| Valuation model | — | — |
| Revenue (FY2025) | EUR 537.08K | USD 8.65M |
| Revenue growth YoY | -39.9% | +5.6% |
| Net income | EUR -16.21M | USD 6.40M |
| Gross margin | 72.6% | 87.2% |
| Diluted EPS | -2.70 | 0.15 |
Figures are in each company's reporting currency — compare growth rates and margins rather than raw amounts.